119 related articles for article (PubMed ID: 12904857)
1. Is prostacyclin an inodilator?
Ricksten SE
Intensive Care Med; 2003 Sep; 29(9):1403-5. PubMed ID: 12904857
[No Abstract] [Full Text] [Related]
2. Getting to the heart of COX-2 inhibition.
Breyer MD
Cell Metab; 2005 Sep; 2(3):149-50. PubMed ID: 16154096
[TBL] [Abstract][Full Text] [Related]
3. Vascular effects of prostacyclin: does activation of PPARδ play a role?
Katusic ZS; Santhanam AV; He T
Trends Pharmacol Sci; 2012 Oct; 33(10):559-64. PubMed ID: 22727878
[TBL] [Abstract][Full Text] [Related]
4. Prostacyclin protects against elevated blood pressure and cardiac fibrosis.
Francois H; Athirakul K; Howell D; Dash R; Mao L; Kim HS; Rockman HA; Fitzgerald GA; Koller BH; Coffman TM
Cell Metab; 2005 Sep; 2(3):201-7. PubMed ID: 16154102
[TBL] [Abstract][Full Text] [Related]
5. [Current conceptions if cardiovascular diseases chemotherapy].
Doshchitsin VL
Klin Med (Mosk); 1997; 75(10):18-21. PubMed ID: 9490331
[No Abstract] [Full Text] [Related]
6. Epoprostenol (prostacyclin) therapy in primary pulmonary hypertension.
Botney M
N Engl J Med; 1998 Jun; 338(24):1773-4. PubMed ID: 9625639
[No Abstract] [Full Text] [Related]
7. Haemodynamic and antihypertensive effect of prostacyclin.
Szczeklik A; Gryglewski RJ; Szczeklik J; Nizankowski R
Adv Exp Med Biol; 1984; 164():299-305. PubMed ID: 6364709
[No Abstract] [Full Text] [Related]
8. Prostacyclin as vasodilator in anaesthesia and intensive care.
Chelly JE
Lancet; 1981 Jul; 2(8239):198. PubMed ID: 6114259
[No Abstract] [Full Text] [Related]
9. Prostacyclin causes splenic dilation and haematological change in dogs.
Noguchi K; Matsuzaki T; Ojiri Y; Sakanashi M; Nakasone J; Sakanashi M
Clin Exp Pharmacol Physiol; 2006; 33(1-2):81-8. PubMed ID: 16445704
[TBL] [Abstract][Full Text] [Related]
10. Sildenafil as adjunct therapy to high-dose epoprostenol in a patient with pulmonary veno-occlusive disease.
Kuroda T; Hirota H; Masaki M; Sugiyama S; Oshima Y; Terai K; Ito A; Yamauchi-Takihara K
Heart Lung Circ; 2006 Apr; 15(2):139-42. PubMed ID: 16574537
[TBL] [Abstract][Full Text] [Related]
11. Aerosolized prostacyclin. In search of the ideal pulmonary vasodilator.
Wetzel RC
Anesthesiology; 1995 Jun; 82(6):1315-7. PubMed ID: 7793644
[No Abstract] [Full Text] [Related]
12. The prostaglandins epoprostenol and iloprost increase left ventricular contractility in vivo.
Kisch-Wedel H; Kemming G; Meisner F; Flondor M; Kuebler WM; Bruhn S; Koehler C; Zwissler B
Intensive Care Med; 2003 Sep; 29(9):1574-83. PubMed ID: 12908096
[TBL] [Abstract][Full Text] [Related]
13. [Chemical and pharmacological study of new derivatives of noradrenaline].
Régnier G; Canevari R; Laubie M; Le Douarec JC
Arzneimittelforschung; 1969 Oct; 19(10):1698-702. PubMed ID: 5395370
[No Abstract] [Full Text] [Related]
14. [Cardiovascular effects of prostacyclin].
Chaignon M; Guelpa G; Lucsko M; Guédon J
Nouv Presse Med; 1982 Dec; 11(50):3717-21. PubMed ID: 6763197
[TBL] [Abstract][Full Text] [Related]
15. Comparative effects of beraprost, a stable analogue of prostacyclin, with PGE(1), nitroglycerin and nifedipine on canine model of vasoconstrictive pulmonary hypertension.
Tamura M; Kurumatani H; Matsushita T
Prostaglandins Leukot Essent Fatty Acids; 2001 Mar; 64(3):197-202. PubMed ID: 11334556
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological profile of LAS 31180, a new inotropic/vasodilator quinolone derivative.
Gras J; Cardelús I; Beleta J; Gristwood RW; Palacios JM; Llenas J
Arzneimittelforschung; 2000 Nov; 50(11):980-6. PubMed ID: 11148864
[TBL] [Abstract][Full Text] [Related]
17. [Pharmacologic study of the cardiovascular system in the Societ Ukraine over 50 years].
Trinus FP
Farmakol Toksikol; 1967; 30(6):646-53. PubMed ID: 4386296
[No Abstract] [Full Text] [Related]
18. Prostacyclin enhances stretch-induced surfactant secretion in alveolar epithelial type II cells.
Rose F; Zwick K; Ghofrani HA; Sibelius U; Seeger W; Walmrath D; Grimminger F
Am J Respir Crit Care Med; 1999 Sep; 160(3):846-51. PubMed ID: 10471607
[TBL] [Abstract][Full Text] [Related]
19. Blood supply can be increased in rabbit skin by a stable prostacyclin derivative without potentiation of plasma extravasation.
Ekerdt R; Luhm H; Töpert M
Br J Dermatol; 1984 Jul; 111 Suppl 27():144-6. PubMed ID: 6204673
[No Abstract] [Full Text] [Related]
20. The effect of prostacyclin as a constituent of a preservation solution in protecting lungs from ischemic injury because of its vasodilatory properties.
Mulvin D; Jones K; Howard R; Grosso M; Repine J; Johnston M
Transplantation; 1990 Apr; 49(4):828-30. PubMed ID: 2109380
[No Abstract] [Full Text] [Related]
[Next] [New Search]
